Seven young boys given Bluebird’s Skysona later developed blood cancers, findings that could shape how doctors [...]

New vaccine aims to protect older adults from severe flu complications Sanofi has announced the launch [...]

What's the outlook for COVID-19 and flu this fall and winter? It'll probably be a lot [...]

A pioneering study led by Dr. Lachlan Jolly at the University of Adelaide’s Neurobiology Research Group [...]

Largest real-world study demonstrates significant survival advantage In a landmark study, Johnson & Johnson has announced [...]

Study results are expected for a pair of closely watched obesity drugs, while key tests await [...]

We’re finally moving towards a causality-based nosology for psychiatry: specific symptoms with defined biological underpinnings can [...]

It is hoped that the tool will improve the diagnostic pathway and free up radiologists’ time [...]

Johnson & Johnson already has a major presence in the crowded inflammatory bowel disease (IBD) space [...]

Patients with relapsed multiple myeloma gain access to life-extending therapy The Scottish Medicines Consortium (SMC) has [...]